ODI Pharma AB: Publication of year-end report
ODI Pharma AB (“ODI” or “the Company”) hereby publishes its year-end report for the period July 2019 – June 2020. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.CEO Derek Simmross comments “The fourth quarter marks the end of our first financial year as a public company, a very important milestone for ODI Pharma. As the COVID-19 pandemic continues to affect societies across the globe, ODI continues to evolve. Even though we are currently facing a delay in the implementation of the